World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
54
Citations
11706
World Ranking
4891
National Ranking
2200

Overview

Adrienne C. Lahti is affiliated with the University of Alabama at Birmingham in the United States. Their research focuses primarily on the fields of Medicine and Neuroscience, with significant contributions to the subfields of Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental Health, Cellular and Molecular Neuroscience, and Neurology.

The main topics addressed in their research include:

  • Functional Brain Connectivity Studies
  • Advanced MRI Techniques and Applications
  • Neuroscience and Neuropharmacology Research
  • Schizophrenia Research and Treatment
  • Advanced Neuroimaging Techniques and Applications
  • Neural Dynamics and Brain Function
  • Neurological Disorders and Treatments

Adrienne C. Lahti has published extensively in several key venues within psychiatry and neuroscience. Frequent publication venues include:

  • Biological Psychiatry
  • Schizophrenia Bulletin
  • Translational Psychiatry
  • Schizophrenia
  • Frontiers in Psychiatry

Notable recent papers authored or co-authored by Lahti include:

  • "The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies," 2020, Schizophrenia Research
  • "Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis," 2020, Translational Psychiatry
  • "Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers," 2020, Neuropsychopharmacology
  • "White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients," 2020, Molecular Psychiatry
  • "Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions," 2024, World Psychiatry

Frequent collaborators in Lahti's research include Nina V. Kraguljac, Jose O. Maximo, Eric Nelson, William P. Armstrong, and Adil Bashir. Their work notably intersects with investigations into brain connectivity, advanced neuroimaging technology, and schizophrenia research.

Best Publications

  • Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

    Adrienne C. Lahti;Bettylou Koffel;David LaPorte;David LaPorte;Carol A. Tamminga

  • Effects of Ketamine in Normal and Schizophrenic Volunteers

    Adrienne C Lahti;Martin A Weiler;B.A Tamara Michaelidis;Arti Parwani

  • Decisional Capacity for Informed Consent in Schizophrenia Research

    William T. Carpenter;James M. Gold;Adrienne C. Lahti;Caleb A. Queern

  • Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

    Adrienne C. Lahti;Henry H. Holcomb;Deborah R. Medoff;Carol A. Tamminga

  • Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

    L Elliot Hong;Ann Summerfelt;Robert W Buchanan;Patricio O'Donnell

  • Probing the human hippocampus using rCBF: contrasts in schizophrenia.

    Deborah R. Medoff;Henry H. Holcomb;Adrienne C. Lahti;Carol A. Tamminga

  • SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

    Stephanie M. Robert;Susan C. Buckingham;Susan L. Campbell;Stefanie Robel

  • Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

    Nina Vanessa Kraguljac;Meredith Reid;David White;Rebecca Jones

  • Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature

    Badari Birur;Nina Vanessa Kraguljac;Richard C. Shelton;Adrienne Carol Lahti

  • Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia

    Nina V. Kraguljac;David M. White;Meredith A. Reid;Adrienne C. Lahti

  • Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia

    Adrienne C Lahti;Martin A Weiler;Henry H Holcomb;Carol A Tamminga

  • Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.

    Juan Francisco Artaloytia;Celso Arango;Adrienne Lahti;Javier Sanz

  • Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.

    Jennifer A Hadley;Rodolphe Nenert;Nina V Kraguljac;Mark S Bolding

  • Functional effects of antipsychotic drugs: comparing clozapine with haloperidol.

    Adrienne C Lahti;Henry H Holcomb;Martin A Weiler;Deborah R Medoff

  • How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference.

    Karen L. Cropsey;Lindsay R. Trent;Charles B. Clark;Erin N. Stevens

  • Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically

    Henry H Holcomb;Adrienne C Lahti;Deborah R Medoff;Martin Weiler

  • Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates.

    Lauren E. Libero;Thomas P. DeRamus;Adrienne C. Lahti;Gopikrishna Deshpande

  • Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

    Adrienne C Lahti;Martin A Weiler;Patricia K Corey;Robert A Lahti

  • Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia

    Meredith A. Reid;Luke E. Stoeckel;David M. White;Kathy B. Avsar

  • Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory.

    Jennifer Ann Hadley;Nina Vanessa Kraguljac;David Matthew White;Lawrence Ver Hoef

  • Treatment of schizophrenia 1999

    B. M. Angrist;R. J. Baldessarini;M. B. Bowers;R. W. Buchanan

Frequent Co-Authors

Carol A. Tamminga
Carol A. Tamminga The University of Texas Southwestern Medical Center
Daniel C. Javitt
Daniel C. Javitt Columbia University
Karen L. Cropsey
Karen L. Cropsey University of Alabama at Birmingham
Rosalinda C. Roberts
Rosalinda C. Roberts University of Alabama at Birmingham
Paul D. Gamlin
Paul D. Gamlin University of Alabama at Birmingham
Melanie M. Wall
Melanie M. Wall Columbia University
Peter S. Hendricks
Peter S. Hendricks University of Alabama at Birmingham
Gregory P. Strauss
Gregory P. Strauss University of Georgia
Noah S. Philip
Noah S. Philip Brown University
Michael F. Green
Michael F. Green University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Adrienne C. Lahti

Trending Scientists

Recently Published Articles